AOS vs TXG · P/E 19, rev $1.00B vs rev $301.9M
Smith AO Corporation (AOS) versus 10X Genomics Inc (TXG) — a side-by-side from cached financials, not a winner call.
Smith AO Corporation (AOS) is a specialty industrial machinery company listed on US.
10X Genomics Inc (TXG) is a health information services company listed on NASDAQ.
Latest reported AOS revenue for 2026-06-30 was $1.00B. Net income was $124.9M. Revenue was up 6.2% from 2026-03-31 to 2026-06-30. AOS currently screens at market cap $9.73B and trailing P/E 19.1.
Latest reported TXG revenue for 2026-06-30 was $301.9M. Net income was -$31.4M. TXG currently screens at market cap $4.08B.
AOS currently screens at market cap $9.73B and trailing P/E 19.1. TXG currently screens at market cap $4.08B.
Not investment advice. Open the AOS and TXG stock pages for the full models.
Not investment advice.